<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
VRCA
Verrica Pharmaceuticals
$
()


  • Verrica announces YCANTH receives new chemical entity status

    3/26/2024 - 07:32am
  • Verrica Pharmaceuticals price target raised by $1 at H.C. Wainwright, here's why

    3/1/2024 - 06:22am
  • Verrica Pharmaceuticals reports Q4 EPS (53c), consensus (53c)

    2/29/2024 - 07:34am
  • Verrica Pharmaceuticals files lawsuit against Dormer Laboratories

    2/5/2024 - 07:34am
  • Verrica Pharmaceuticals receives permanent J-Code for YCANTH from CMS

    1/29/2024 - 07:32am
  • Verrica Pharmaceuticals announces last patient dosed in Phase 2 trial of VP-315

    1/5/2024 - 07:30am
  • Verrica Pharmaceuticals receives Type C meeting minutes on YCANTH development

    1/4/2024 - 07:32am
  • Verrica Pharmaceuticals announces specialty pharmacy agreement with Walgreens

    1/3/2024 - 07:32am
  • Biotech Alert: Searches spiking for these stocks today

    12/18/2023 - 10:54am
  • Fly Intel: Pre-market Movers

    12/15/2023 - 08:57am
  • Torii Pharmaceutical reports 'positive' results from Phase 3 trial of TO-208

    12/15/2023 - 06:02am
  • Verrica Pharmaceuticals reports Q3 EPS (54c), consensus (36c)

    11/9/2023 - 07:34am
  • Verrica Pharmaceuticals to host KOL event discussing YCANTH approval

    9/27/2023 - 08:12am
  • Verrica Pharmaceuticals announces first sale of YCANTH to FFF Enterprises

    8/24/2023 - 08:32am
  • Verrica issues statement in support of FDA's letters on treatment of MC

    8/23/2023 - 07:31am
dynamic_feed Breaking News